Biotechnology – Medical Alley Association

Biotechnology

Kindeva and BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid Products

St. Paul, MN (December 1, 2020) – Kindeva Drug Delivery (Kindeva) and Breath of Life International (BOL Pharma or BOL) have signed an agreement to study the feasibility of multiple inhaled cannabinoid products. Under the agreement, Kindeva will develop novel formulations of BOL Pharma’s cannabinoid-based drug products delivered by Kindeva’s metered-dose inhaler (MDI) technology.  Subject […]

StemoniX Announces Publication Demonstrating High-throughput Screening Using Human-derived CNS Models

MAPLE GROVE, MN and SAN DIEGO, CA November 12, 2020 — StemoniX, Inc. announced the publication of a new research paper, “Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroids,” in the journal PLOS ONE. The research describes how the StemoniX microBrain 3D platform can be used in functional high-throughput screens to […]

REGENHU Opens New Office in Edina, Minnesota

Villaz-St-Pierre, Switzerland – 06 November 2020 – REGENHU, a leading, global provider of bioprinting technologies, announced today the opening of its office in Minnesota, United States, establishing its presence in North America.  This company’s first office in the US, located in Medical Alley, Minnesota, officially opened its doors last Monday. It will serve as the […]

Midbrain Organoids for Automated Chemical Screening and Disease Research

Max Planck Innovation licenses process for the generation of organ-like tissue aggregates to biotech company StemoniX November 03, 2020 – Sometimes hundreds of thousands of potential therapeutics need to be tested in large-scale, fully automated experiments to identify a single effective drug. Most compounds do not work as desired, and some are even toxic. Since […]

BlueAllele Launches PALIDON™ Gene Editing Technology to Discover and Develop Therapies for Genetic Diseases

Oakdale, Minnesota, July 23 — BlueAllele, a biotechnology company focused on enhancing the quality and precision of gene editing systems for patients with genetic diseases, announced the launch of PALIDON™, an innovative and proprietary repair template technology. Many rare genetic diseases are caused by mutations within a single gene. However, the location of the mutation often […]

StemoniX ® CEO, Ping Yeh, Participates in an Organ- on-a-Chip and AI Focused Panel at the BIO2020 Digital Convention

Yeh discusses how the StemoniX microOrgan platforms and specialized AI AnalytiX™ software are driving drug discovery and development. MAPLE GROVE, MN, JUNE 9, 2020 – StemoniX ® , Inc., a biotech company revolutionizing how new medicines are discovered, announced today that its CEO and Co-founder, Ping Yeh, has joined a panel of experts from the […]

Pfizer Establishes New Program to Support Continued Biotechnology Innovation

Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies June 02, 2020 06:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help […]

Ecolab supports cleanroom environments for the University of Oxford’s Clinical BioManufacturing Facility COVID-19 vaccine development and manufacture

More than three billion people are currently experiencing some form of restriction on their movement or are in lockdown to try to slow the spread of COVID-19.  A global race is underway to develop a vaccine or drug treatment to halt the pandemic.  The Jenner Institute, University of Oxford, has announced significant progress in developing and […]

BARDA Industry Days

By Diane Rucker (UEL) Kate Evinger (gener8tor) and I joined BARDA Industry Days last week in Washington, DC.  In September, University Enterprise Labs (UEL) and gener8tor announced a partnership to support startups in health security, funded by a federal grant.  (The federal government loves acronyms.  I’ll include translations in the article.) But first, some fun […]

Miromatrix Awarded $1.9 Million NIH Grant to Advance the Development of a Bioengineered Liver

Miromatrix Inc., a Minnesota-based biotechnology company, was awarded a $1,970,000 Direct to Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to advance the development of a bioengineered transplantable liver to address the chronic shortage of transplantable […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER